activity of MLCK in elongated filopodia formation and chemotaxis of vascular smooth muscle cells toward sphingosylphosphorylcholine. Am J Physiol Heart Circ Physiol 296: H1683-H1693, 2009. First published February 20, 2009 doi:10.1152/ajpheart.00965.2008.-The actin-myosin interaction of vascular smooth muscle cells (VSMCs) is regulated by myosin light chain kinase (MLCK), which is a fusion protein of the central catalytic domain with the N-terminal actin-binding and Cterminal myosin-binding domains. In addition to the regulatory role of kinase activity mediated by the catalytic domain, nonkinase activity that derives from both terminals is able to exert a regulatory role as reviewed by Nakamura et al. (32). We previously showed that nonkinase activity mediated the filopodia upon the stimulation by sphingosylphosphorylcholine (SPC) (25). To explore the regulatory role of nonkinase activity in chemotaxis, we constructed VSMCs where the expression of MLCK was totally abolished by using a lentivirusmediated RNAi system. We hypothesized that the MLCK-downregulated VSMCs were unable to form filopodia and to migrate upon SPC stimulation and confirmed the hypothesis. We further constructed a kinase-inactive mutant from bovine cDNA coding wild-type (WT) MLCK by mutating the ATP-binding sites located in the catalytic domain, followed by confirming the presence (absence) of the kinase activity of WT (kinase-inactive mutant). We transfected WT and the mutant into MLCK-downregulated VSMCs. We expected that the transfected VSMCs will recover the ability to induce filopodia and chemotaxis toward SPC and found both constructs rescued the ability. Because they share the actin-and myosin-binding domains, we concluded nonkinase activity plays a major role for SPC-induced migration.
chemotaxis; myosin light chain kinase VASCULAR SMOOTH MUSCLE cell (VSMC) chemotaxis plays a key role in vessel remodeling during vascular development (15) and in the pathology of atherosclerosis in response to vascular injury (51) . During atherogenesis, VSMCs migrate from the media to the intima in response to such mediators as growth factors and cytokines released from different cell types, including endothelial cells, platelets, and inflammatory cells after intima injury (51) . Migration of medial VSMC to the intima involves chemotaxis, which is defined as directed migration toward a concentration gradient of extracellular signals (48) . The process of cell chemotaxis is commonly described as a cycle of coordinated steps. First, the cell extends membrane protrusion in the intended direction of movement, and then the extended membrane is stabilized via the formation of new adhesion sites. Next is the forward translocation of the cell body, accompanied by tail detachment and retraction in which the cell undergoes contraction (31, 49) . Early signaling events cause actin polymerization-based protrusions of the leading edge of cells toward the chemotactic stimulus (11, 37) . Filopodia, one of the protrusions at the leading edge of a motile cell, contributes in the probing of the microenvironment and directional sensing of the chemotactic signals in chemotaxis (12, 29) .
Sphingosylphosphorylcholine (SPC), a sphingomyelin metabolite, is thought to regulate various physiological and pathological phenomena, including blood vessel constriction, inflammation, and chemotaxis of VSMCs (30, 33) . For example, it causes the release of inflammatory mediators from the activated platelets in inflammatory swelling, and it also changes VSMCs from contractile type to proliferative type at the atherosclerotic plaque, indicating an active role in the pathogenesis of vascular disease (33, 34) . At the cellular level, SPC stimulates the chemotaxis of VSMCs in the Boyden chamber assay (4, 25) . SPC also induces the reorganization of the actin cytoskeleton with the appearance of filopodia at the cell periphery in both VSMCs and in fibroblasts (25, 41, 52) . Downstream factors of SPC in cell chemotaxis are still unknown. However, myosin light chain (MLC) kinase (MLCK) is suggested to be involved in cell chemotaxis in a variety of cell species (1, 20, 42, 43, 47, 50) . MLCK is a specific kinase for smooth and nonmuscle myosin IIs. It phosphorylates the 20-kDa MLC (MLC20) in the presence of Ca 2ϩ and calmodulin and activates the interaction between myosin II and actin filaments both in vitro and in vivo (16, 17, 44) . Inhibition of MLCK activity by overexpressing the pseudosubstrate for MLC phosphorylation attenuates chemotaxis of fibroblasts (47) . Transfection of cDNA of the constitutively active form of MAPK enhances MLCK activity and thus increases MLC phosphorylation and cell chemotaxis (20) . These results suggest that the kinase activity plays an important role in cell chemotaxis processes.
In the domain structure of MLCK, the central portion of MLCK is responsible for the phosphorylation as described above. MLCK is a fusion protein that includes actin-binding (myosin-binding) domains at its N-terminal (C-terminal) (21, 36) . As reviewed in Nakamura et al. (32) , we named MLCK nonkinase activities from the N-terminal and/or C-terminal domains in addition to MLCK kinase activity. The actinbinding domain attenuates the ATPase activity of myosin II (22, 53) and the sliding of actin filament on the myosin II-coated surface (10, 32), whereas the myosin-binding domain stimulates the ATPase activity of myosin II (54) . MLCK also functions to assemble actin filaments (14, 23) .
The role of the nonkinase activity was characterized mostly in vitro (9, 32) . We hypothesized that the regulation of the interaction between actin and myosin by the nonkinase activity should play an important role in vivo, i.e., in living VSMCs. One of the approaches to the hypothesis is to downregulate the MLCK expression. Although we previously downregulated MLCK by introducing antisense cDNA of MLCK (2, 19) , the finding of MLCK isoforms (3) complicated the interpretation of the results due to the presence of the long MLCK isoform. Therefore, we designed RNAi of MLCK for the downregulation. The use of a lentiviral vector to introduce RNAi completely and stably eliminated the expression of MLCK isoforms. We introduced MLCK cDNA plasmids of wild-type (WT) or the mutant devoid of the kinase activity into the downregulated cells and then treated the downregulated VSMC and the rescued VSMC with SPC. We observed that both constructs caused filopodia formation and chemotaxis. Because both constructs were furnished with the actin-binding and myosin II-binding domains, we interpreted our observation that nonkinase activity plays a major role in the filopodia formation and chemotaxis.
MATERIALS AND METHODS
Cell culture. A7r5 cells, a VSMC line derived from embryonic rat aorta purchased from the American Type Culture Collection, were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS), 100 U/ml penicillin, and 100 g/ml streptomycin. GbaSM-4 cells, a VSMC line derived from the brain basilar artery of guinea pigs (18, 35) , and SM3 cells, a VSMC line established from rabbit aorta smooth muscle (38) , were cultured as described above. These VSMCs were used to examine chemotaxis and filopodia formation. Cells were incubated in a humidified incubator (37°C, 5% CO 2-95% air) and passaged upon reaching 90% confluence.
Antibodies and reagents. SPC was purchased from Biomol and dissolved in methanol. Y27632 and SB203580 were from Calbiochem. Fluorescein isothiocyanate (FITC)-conjugated phalloidin was purchased from Molecular Probes. Fura-2 AM was obtained from Dojin Laboratories. Lysophosphatidic acid (LPA), monoclonal antibody (clone K36) against MLCK, and monoclonal antibody (clone M2) against Flag were obtained from Sigma.
Measurement of intracellular Ca 2ϩ concentration. The intracellular Ca 2ϩ concentration ([Ca 2ϩ ]i) in VSMCs in response to SPC or LPA stimulation was monitored using fura-2, as described previously (25) . Briefly, cells cultured on coverslips were incubated with 5 M fura-2 AM in modified Hank's solution containing (in mM) 140 NaCl, 2.8 KCl, 0.5 CaCl 2, 2 MgCl2, and 10 HEPES (pH 7.2) for 45 min at 37°C. Fura-2 AM incorporated into the cells was excited alternatively at 340 nm and 380 nm with emission recorded at 510 nm using an Aquacosmos system equipped with an Oraca II cold charge-coupled device camera (Hamamatsu). The ratio of the emission signals was used as a relative [Ca 2ϩ ]i. Transient downregulation of MLCK in VSMCs by small interfering RNA. Several small interfering RNA (siRNA) targeting sequences of MLCK genes of three cell lines were determined by the Invitrogen BLOCK-iT RNAi Designer online program (https://rnaidesigner. invitrogen.com/rnaiexpress/) according to the gene sequences of guinea pig smooth muscle MLCK (accession number AB070227), rat smooth muscle MLCK (accession number NM057209), and rabbit smooth muscle MLCK (accession number M76233), respectively. The scrambled siRNAs with nonspecific nucleotide sequences were designed by an online designer (http://www.sirnawizard.com/ scrambled.php). The siRNA-targeted sequences were as follows: GbaSM-4 (guinea pigs): 5Ј-AAGTATCTGACCTGTACGACA-3Ј(GsiRNA) and 5Ј-GCGTCGAATCCGCAATAATTA-3Ј (Gscramble); A7r5 (rat): 5Ј-AAGTATCTGATGTATATGACA-3Ј (AsiRNA) and 5Ј-GGTAATATCGTATAGAACTTA-3Ј (Ascramble); and SM3 (rabbit): 5Ј-AAGAAGTACATGGCAAGAAGA-3Ј (SsiRNA) and 5Ј-GAGGGACAACGAATAGAAATA-3Ј (Sscramble). The siRNA fragments were chemically synthesized by NIPPON EGT. Transfection of siRNA fragments into the cells was performed by using Nucleofector electroporation (Amaxa), according to manufacturer's instructions. The transformant cells were used for experiments during 48 to 72 h after the transfection.
Establishment of a GbaSM-4 cell line constitutively lacking the expression of short and long MLCKs by lentiviral-mediated RNAi. The lentivirus containing short hairpin RNA (shRNA) interference was raised according to the manufacturer's protocol (BLOCK-iT U6 Lentiviral RNAi kits; Invitrogen). Briefly, shRNAs were designed to target the guinea pig smooth muscle MLCK (accession number AB070227), but not the bovine smooth muscle MLCK (BsMLCK) (accession number S57131), using the Invitrogen BLOCK-iT RNAi Designer online program (https://rnaidesigner.invitrogen.com/rnaiexpress/). The DNA sequences thus obtained [(top strand) 5Ј-CACCGAAG-TATCTGACCTGTACGACACGAATGTCGTACAGGTCAGATAC-3Ј and (bottom strand) 5Ј-AAAAGTATCTGACCTGTACGACAT-TCGTGTCGTACAGGTCAGATACTTC-3Ј; underlined letters are loop sequence] were commercially synthesized, annealed, and ligated into the pENTR/U6 (Invitrogen). Gateway (attL ϫ attR) recombination (LR) recombined reaction was performed to transfer the pENTR/ U6-MLCK shRNA constructs into the pLenti6/BLOCK-iT expression vector (Invitrogen) using LR clonase enzyme mix following the manufacturer's instructions. Lentiviruses encoding shRNAs were generated by cotransfecting 293T cells with the pLenti6/BLOCK-iT expression construct, along with ViraPower Packaging mix by Lipofectamine 2000, as described in the supplier's manual. Conditioned medium was harvested 72 h after transfection and filtered through 0.45-m filters. GbaSM-4 cells were incubated with virus-containing condition media (titer ϭ 2.8 ϫ10 5 transducing unit/ml) supplemented with polybrene (6 g/ml) for 14 days. A blasticidin-resistant colony was selected and expanded, and the expressions of MLCKs were determined by Western blot. The GbaSM-4 cell line constitutively lacking the expression of MLCK thus established was named MLCK RNAi cells.
Plasmid construction of the WT and kinase-inactive MLCKs. Fulllength of BsMLCK cDNA (accession number S57131) maintained in pUC118/BS155K was a gift from Prof. Setsurou Ebashi (21) . pUC118/ BS155K was used as a template to generate a new plasmid named pUC118/kinase-inactive, which contained the cDNA that encoded the kinase-inactive mutant of MLCK by mutagenesis described. As a member of the protein-serine/threonine kinase family, MLCK has consensus Gly-X-Gly-X-X-Gly residues to form an elbow around nucleotide and directly participate in ATP binding in which the first Gly contact lay with the ribose moiety and the second Gly lay near the terminal pyrophosphate (13) . Kinase-inactive mutant was constructed by replacing the three Gly in the ATP-binding site of BsMLCK (Gly732, Gly734 and Gly737) with Ala by using the QuickChange Site-Directed Mutagenesis kit (Stratagene). The following two sequences were used as primers: 5Ј-GCATCTGCGAAATTTGCA-CAGGTCTTTCGAC-3Ј and 5Ј-TGTGCAAATTTCGCAGATGCT-AGTCTCTCTCTTCG-3Ј. After the Flag-tag sequence was ligated in its N-terminal, the full-length or kinase-inactive BsMLCK cDNA was subcloned into pCDNA3.1 (Invitrogen). The two constructs were named Flag-MLCK cDNA and Flag-kinase-inactive MLCK cDNA. Transfection of cDNAs into MLCK RNAi cells was performed by using Nucleofector electroporation (Amaxa), according to manufacturer's instructions. The transformant cells were used for experiments during 48 to 72 h after transfection. The inactive nature of kinase activity of MLCK was shown in supplemental materials (all supplemental material can be found with the online version of this article).
Immunoblot. VSMCs or transfected cells were extracted with lysis buffer containing 50 mM Tris ⅐ HCl (pH 7.5), 150 mM NaCl, 1% Nonidet P-40, 0.05% sodium deoxycholate, and 0.1% SDS, as previously described (8) . Protein concentrations were determined using a protein assay kit (Bio-Rad) with BSA as a standard (5) . The lysates (total 20 g) were separated by 8% SDS-PAGE (24) and transferred to a polyvinylidene difluoride membrane; the membranes were then incubated with a monoclonal antibody specific for MLCK (clone K36; Sigma) or a monoclonal antibody specific for Flag (clone M2; Sigma). After incubation with horseradish peroxidase (HRP)-conjugated secondary antibody against mouse IgGs (Convance), the blots were visualized using an Immobilon Western chemiluminescent HRP substrate (Millipore). For the loading control, they were examined by a monoclonal antibody specific for ␤-actin (clone AC-15; Sigma).
Immunofluorescence. VSMCs or transformant cells were seeded on type I collagen (Cellmatrix type I-C; Nitta Gelatin)-coated eight-well slide chambers at 3 ϫ 10 3 cells per well in culture medium for 2 days. Cells were then quiesced in serum-free DMEM/0.1% BSA for 12 h, and the medium was replaced with DMEM/0.1% BSA with or without SPC (1 M) for up to 30 min. After cells were fixed in 1.5% paraformaldehyde in phosphate-buffered saline (PBS) for 5 min, they were washed with PBS and permeablized with 1% Triton X-100 in PBS. After cells were blocked with 5% BSA in PBS for 1 h, the cells were incubated with FITC-phalloidin (Molecular Probes) for 1 h. In some cases, cells were incubated with anti-Flag monoclonal antibody (clone M2; Sigma) at 4°C overnight, followed by incubation with RedX-conjugated mouse secondary antibody (Jackson ImmunoResearch) and FITC-phalloidin for 1 h. After being washed with 1% BSA in PBS, cells were mounted with 50% (wt/vol) glycerol in PBS and observed by LSM510META laser confocal microscopy (Carl Zeiss). For quantification of filopodia, more than 100 cells per well were evaluated under the microscope, and the percentage of cells that indicated five or more filopodia was calculated. Experiments were repeated on three independent occasions.
Chemotaxis assay. Chemotaxis of VSMCs was assayed by the Boyden chamber method as previously described (19) . VSMCs suspended in DMEM containing 0.2% BSA were counted and then applied to the upper compartments of the Boyden chamber (Neuroprobe) equipped with 8-m-pore polycarbonate membrane coated with type I collagen (Cellmatrix type I-C; Nitta Gelatin). DMEM containing 0.2% BSA in the presence of 1 M SPC was introduced into the lower compartments of the Boyden chamber. The apparatus was incubated at 37°C in a 5% CO 2 incubator for 10 h; the polycarbonate membrane was then fixed with methanol for 2 h at room temperature, followed by staining with Giemsa. The cells that had migrated to the lower surface of the membrane were counted under the microscope, and the sum of the numbers of cells from five randomly chosen microscopic fields (magnification ϫ400; area ϭ 0.14 mm 2 ) was determined as the number of migrating cells in each well. Experiments were performed in quadruple and repeated on three separate occasions.
Statistics. Statistical significance was determined by Student's t-test using Sigma Stat version 3.1, and P Ͻ 0.001 was considered statistically significant.
RESULTS

SPC-induced filopodia formation and chemotaxis in a variety of VSMCs.
We previously reported that SPC induced actin remodeling and the formation of filopodia and enhanced cell chemotaxis (25) . To confirm whether these responses against SPC were common phenomena in VSMCs, we treated the A7r5 cells and SM3 cells as well as GbaSM-4 cells with 1 M SPC and examined the filopodia formation (Fig. 1) . SPC treatment significantly induced the formation of filopodia in three different VSMC lines (Fig. 1A) . In the presence of SPC, 11% of GbaSM-4 cells formed six or more elongated filopodia at the cell peripheral (Fig. 1B, black bar) , whereas 83% of the cells formed six or more elongated filopodia upon the stimulation of SPC (Fig. 1B, gray bar) , confirming the previous report from our laboratory (25) . Similar results were obtained in A7r5 cells (3% in the absence of SPC and 57% in the presence of SPC) and SM3 cells (7% in the absence of SPC and 60% in the presence of SPC), indicating that SPC-induced filopodia formation is a common phenomenon in VSMCs.
We next investigated the SPC-induced chemotaxis of VSMCs by the Boyden chamber. As illustrated in Fig. 2A, ] i elevation-independent processes (for the effect of LPA on the migratory activity, see the supplemental Fig. 3) .
MLCK is essential for SPC-induced filopodia formation and chemotaxis in VSMCs. Because MLCK is suggested to control cell chemotaxis in a variety of cell types (1, 20, 43, 47, 50) , we examined the role of MLCK in filopodia formation and chemotaxis induced by SPC. First, we examined the expressions of MLCK in GbaSM-4 cells, A7r5 cells, and SM3 cells by Western blotting (Fig. 2C) . Expressions of both long MLCK with a molecular mass of 220 kDa and short MLCK with a molecular mass of 130 kDa have been observed in rodent VSMCs. Our antibody used to detect MLCK cross-reacted to both types of MLCK. We found 130 kD MLCK in all three VSMC lines (Fig. 2C, center panels) and 220 kD MLCK in GbaSM-4 cells and A7r5 cells (Fig. 2C, top panels) . It should be noted that MLCK expressions were not dramatically changed before and after stimulation of SPC (Fig. 2C) , suggesting that SPC-induced filopodia formation and chemotaxis are not regulated by MLCK expression.
To evaluate the role of MLCK in filopodia formation and chemotaxis in VSMCs, we transfected several siRNA fragments and their scrambled controls into GbaSM-4, A7r5, and SM3 cells. We found that siRNA depressed the expression levels of MLCK in the three cell lines compared with respective scrambled controls (Fig. 3A) . We then examined the filopodia formation and chemotaxis of these transfected cells. The filopodia formation and chemotaxis toward SPC were effectively depressed by above siRNAs when they were compared with the respective scrambled controls in three VSMC lines (Fig. 3, B and C) . We concluded that MLCK should be necessary for SPC-induced filopodia formation and chemotaxis in VSMCs.
It must be noted that the siRNA is unable to downregulate the long and short isoforms at once (Fig. 3A) . To avoid the complication due to the remaining MLCK isoform after siRNA fragment transfection, we constructed a stable GbaSM-4 cell line whose MLCK expression was suppressed by lentiviralmediated RNAi and named them MLCK-RNAi cells. In these MLCK-RNAi cells, 220 kDa MLCK were undetected and 130 kDa MLCK were only slightly detected (Fig. 4B ), indicating that we had successfully obtained the MLCK-downregulated cell line. Using these MLCK-RNAi cells, we examined the SPC-dependent filopodia formation (Fig. 5) . SPC could not induce the formation of filopodia in the MLCK-RNAi cells compared with the GbaSM-4 cells (Fig. 5A) . When we quantified the number of filopodia-formed cells, less than 1.3% of MLCK-RNAi cells formed six or more filopodia in the absence of SPC, and this value was unchanged in the presence of SPC (2%; Fig. 5B ). We also examined the chemotaxis toward SPC in MLCK-RNAi cells. As indicated in Fig. 5C , the number of cells migrating toward SPC was unchanged in the presence and absence of SPC. These results suggest that MLCK is necessary for SPC-induced filopodia formation and chemotaxis in GbaSM-4 cells.
To confirm these results, we transfected the exogenous bovine MLCK cDNA tagged with Flag into MLCK RNAi cells (named Flag-MLCK cells) and examined whether SPC-induced filopodia formation and chemotaxis were recovered. As Fig. 4B reveals, Flag-MLCK cells expressed the 155 kDa bovine MLCK, and this expression was confirmed by Western blotting using specific antibodies against Flag and MLCK. In Flag-MLCK cells, filopodia formation was recovered (or slightly increased) to the level of GbaSM-4 cells in the absence of SPC (Fig. 5B ), suggesting that the expression level of MLCK may affect spontaneous filopodia formation. In the presence of SPC, the number of cells that formed six or more filopodia increased twice that in the absence of SPC in Flag-MLCK cells, indicating that SPC-induced filopodia formation was restored. The chemotaxis toward SPC was also recovered in Flag-MLCK cells (Fig. 5C ). These results suggest that MLCK plays an essential role in SPC-induced filopodia formation and chemotaxis.
Kinase activity of MLCK is not necessary to restore filopodia formation and chemotaxis in MLCK-RNAi cells. Does MLCK work in SPC-induced filopodia formation and chemotaxis through its kinase activity for myosin II? To address this question, we constructed a cDNA that encoded the kinaseinactive mutant of bovine MLCK with a Flag epitope in its N terminal (Fig. 4A) . The cells transfected with the above vector into MLCK-RNAi cells were named Flag-kinase-inactive MLCK cells. As indicated in Fig. 4A , Flag-kinase-inactive MLCK cells expressed exogenous 155 kDa Flag-kinase-inactive MLCK peptide, although its expression level was lower than that of Flag-MLCK peptides in Flag-MLCK cells. We also confirmed that Flag-kinase-inactive MLCK peptides purified from bacterial expression system lost kinase activity as shown in supplemental Fig. 1 .
Concerning cytoskeleton, Flag-kinase-inactive MLCK construct as well as WT of Flag-MLCK construct restored filopodia formation upon SPC stimulation (Fig. 5, A and B) . Flag-kinase-inactive MLCK peptide as well as Flag-MLCK peptide localized in filopodia and colocalized with F-actin (Fig.  5A ). As shown in supplemental Fig. 2 , the formation of stress fiber also appeared to be recovered. The data concerning cytoskeleton support the important role of nonkinase activity in the filament formation. Flag-MLCK construct as well as Flag- Fig. 3 . Downregulation of MLCK in VSMCs inhibits the filopodia formation and chemotaxis upon SPC stimulation. A: 48 h after transfection with RNAi and scramble control, the expression levels of MLCK of 3 VSMC lines were detected by Western blots as described in MATERIALS AND METHODS. B: 48 h after RNAi transfection, VSMCs were stimulated with 1 M SPC for 30 min or vehicle as a control. Cells were stained with FITC-phalloidin to visualize F-actin followed by quantification of filopodia formation. Cells were counted as described in the Fig. 1B legend. For each experiment, 50 cells were evaluated, and values are represented as means Ϯ SD of 3 independent experiments. **P Ͻ 0.001, small interfering RNA (siRNA) transfected group vs. scrambled siRNA transfected group, respectively. C: 48 h after RNAi transfection, VSMCs were transferred into the upper chamber of Boyden chamber and were allowed to migrate toward 1 M SPC. For other details, see Fig. 2A legend. Data represent means Ϯ SD of 4 independent experiments. **P Ͻ 0.001, siRNA transfected group vs. scrambled siRNA transfected group, respectively. kinase-inactive MLCK construct increased the number of cells that migrated to SPC (Fig. 5C ). However, we must admit that full recovery was not achieved compared with untreated GbaSM-4 (Fig. 5C ), i.e., ϳ84% recovery with Flag-MLCK construct and ϳ61% recovery with Flag-kinase-inactive MLCK construct, but that the recovery caused by the both constructs was statistically significant. The lower recovery with Flag-kinase-inactive MLCK should be related to the lower expression level of 155-kDa peptide as shown in Fig. 4B . Because both constructs were furnished with nonkinase activity, we interpreted that SPC-induced filopodia formation and chemotaxis is controlled through nonkinase activity of MLCK.
Effects of inhibitors of Rho-kinase and p38 MAPK on the rescued cells. We discussed in the previous report that filopodia formation and migration upon SPC stimulation acted via a signal transduction pathway that is independent of kinase activity of MLCK (25) . In the cells where MLCK expression was downregulated, i.e., the cells named MLCK-RNAi, the activities of Rho-kinase and p38 MAPK should persist. We expect that inhibition of the activities in the cells that were rescued by the transfection of Flag-kinase-inactive MLCK construct should elucidate the role of nonkinase activity in cell migration. To confirm the expectation, we examined the effect of Y27632 as a Rho-kinase inhibitor and SB203580 as a p38 MAPK inhibitor on the rescued cells.
As shown in Fig. 6 , the rescued cells mentioned above showed migratory activity toward SPC, confirming the data shown in Fig. 5C . We observed that the migration was inhibited in the presence of 10 M Y27632 or 50 M SB203580. We also observed the same effects of inhibitors in the cells transfected by Flag-MLCK (Fig. 6) . Because both Flag-kinaseinactive MLCK and Flag-MLCK constructs are furnished with nonkinase activity, we interpreted the results that nonkinase activity was related to the signal transduction pathways related to the pathway of both Rho-kinase and p38 MAPK.
DISCUSSION
The present study confirms that SPC induces filopodia formation (Fig. 1) and chemotaxis toward SPC ( Fig. 2A) in VSMCs of GbaSM-4, A7r5, and SM3. Downregulation of MLCK in VSMCs attenuates SPC-induced filopodia formation (Figs. 3B and 5B) and chemotaxis (Figs. 3C and 5C ), which are recovered by expressing exogenous WT MLCK cDNA in downregulated cells (Fig. 5, B and C) . Expression of the exogenous kinase-inactive mutant of MLCK also restores filopodia formation (Fig. 5, A and B) and chemotaxis (Fig. 5C ) in MLCK-downregulated cells.
Additionally, [Ca 2ϩ ] i is suggested to be involved in cell chemotaxis and actin remodeling in a variety of cells, including VSMCs (11) . SPC increases [Ca 2ϩ ] i via influx through L-type channels and/or mobilization from inositol 1,4,5-trisphosphate (IP 3 )-sensitive stores, depending on cell types and species (30, 33) . In VSMCs, for example, the SPC-induced [Ca 2ϩ ] i increase in rat cerebral arteries is eliminated by the pretreatment of a specific inhibitor for L-type membrane channels (28) ] i increase and IP 3 generation are eliminated by pretreatment of Gi-specific inhibitor pertussis toxin in porcine aortic smooth muscle cells (6) , suggesting that mobilization from IP 3 -sensitive stores is responsible for the SPC-induced [Ca 2ϩ ] i increase in these cells. These heterogeneities in response to SPC may depend on differential expression of SPC receptors or downstream regulatory proteins. Our laboratory, as well as others, previously reported that optimal SPC concentration of chemotaxis toward SPC is 0.5 to 1 M in human aortic VSMC (4) or in GbaSM-4 VSMC (25) . At this concentration of SPC, no [Ca 2ϩ ] i increase is observed in most VSMCs (25, 28, 45, 46 ) except porcine aortic smooth muscle, whose EC 50 is 1 M (6). In our experiment system, no increase in [Ca 2ϩ ] i was observed in GbaSM-4 cells, A7r5 cells, and SM3 cells (Fig. 2B) . Thus it seems likely that SPC-induced filopodia formation (Fig. 1) and chemotaxis toward SPC ( Fig. 2A) (Figs. 3 and 5) . MLCK is a multifunctional protein whose major role is to phosphorylate MLC20 and activate myosin II in smooth muscle and nonmuscle cells (16) . This phosphorylation process requires Ca 2ϩ and calmodulin (16, 17, 44) , indicating that the kinase activity of MLCK may play a small role, if any. The limited role is supported by the observation that the transfection of the kinaseinactive mutant of MLCK cDNA, which is furnished with only nonkinase activity, restores filopodia formation and chemotaxis (Fig. 5) . In addition, MLCK exhibits actin-binding activity (7, 27, 39) and actin-bundling activity (14, 23) ; it promotes actin-myosin II interaction through its myosin-binding activity (54) and attenuates actin-myosin II interaction through its actin-binding activity (10, 32) . We believe that some of these properties may be involved in SPC-induced filopodia formation. Both Flag-MLCK and Flag-kinase-inactive MLCK localized in filopodia in MLCK RNAi cells (Fig. 5A) after SPC stimulation. Furthermore, spontaneous filopodia formations without SPC stimulation decrease in MLCK-RNAi cells that are recovered after exogenous transfection of MLCK cDNA (Fig. 5B, black bars) . These results suggest that MLCK may work as an essential structural protein to form filopodia upon SPC stimulation. It is also speculated that the promoting activity of MLCK in the actin-myosin interaction may enhance chemotaxis because activation of myosin II activity is necessary, at least in part, for various types of cell chemotaxis (11) . In our experiment system, SPC stimulation did not accompany an increase in [Ca 2ϩ ] i (Fig. 2B) . Because kinase activity of MLCK is dependent on calcium and calmodulin (16, 17, 44) , kinase activity may not play an essential role in chemotaxis upon SPC stimulation. We observed that Rho-kinase inhibition and p38 MAPK inhibition reduced chemotaxis activity of Flag-MLCK cells and Flag-kinase-inactive MLCK cells (Fig.  6) . What is important is the inhibitory effect on the latter cells that do not express kinase activity. We interpreted the observation that nonkinase activity of MLCK is related to Rhokinase and p38 MAPK pathways. On the other hand, LPA increased [Ca 2ϩ ] i ,as shown in Fig. 2B . Does kinase activity of MLCK relate to the signal transduction pathway that follows to LPA stimulation? To answer the question, we compared migratory activity of control GbaSM-4 with that of MLCK-RNAi cells, which are devoid of MLCK expression. We found that MLCK-RNAi cells migrate toward LPA. Thus we concluded that LPA works via the signal transduction pathway that does not relate to kinase activity of MLCK nor nonkinase activity of MLCK.
SPC treatment also induces the activation of p42/44 MAPK (ERK1/2) (25, 40) and p38 MAPK (25, 28) . p42/44 MAPKs phosphorylate MLCK and promote MLCK activity, MLC20 phosphorylation, and cell chemotaxis in COS-7 cells (20) . However, since this promotion process requires Ca 2ϩ and calmodulin (20) , it is unlikely that the p42/44 MAPKs:MLCK cascade is responsible for SPC-induced chemotaxis in VSMCs. Indeed, we previously found that the specific inhibitor for p42/44 MAPK failed to inhibit cell chemotaxis toward SPC (25) . However, the specific inhibitor for p38 MAPK partially attenuated SPC-induced chemotaxis (25) , suggesting that the activation of p38 MAPK is required, at least in part, for chemotaxis toward SPC. At this point, we do not know whether MLCK lies downstream of the SPC:p38 MAPK cascade (25) , but it is probable that nonkinase activities of MLCK are regulated by p38 MAPK. Further characterizations concerning the regulatory mode of MLCK have yet to be demonstrated.
Filopodia are generally thought to work in migrating cells as antenna that sense the environment around the cells and guide the cells toward proper destinations, although the molecular mechanisms remain unclear (12, 29) . Therefore, our findings of SPC-induced filopodia formation ( Fig. 1 ) and chemotaxis toward SPC (Fig. 2 ) are likely to be one set of sequential phenomena. SPC concentrations in plasma are 50 nM, and those of serum are 130 nM (26), which are not optimal but are sufficient to induce chemotaxis toward SPC in VSMCs (4, 25) . Therefore, we must admit that the effects of SPC in the present study (Figs. 1A and 5A and supplemental Fig. 2) were not adequate to demonstrate the pathological significance, especially in terms of SPC concentration (33) . Recognizing the flaw, we would like to conclude that the nonkinase activity of MLCK is essential for SPC-induced chemotaxis and may work as a regulatory system in physiological and pathological processes.
